World's Best Scientists 2026 revealed!
Morie A. Gertz

Morie A. Gertz

D-Index & Metrics

Medicine

D-Index
159
Citations
106909
World Ranking
810
National Ranking
456

Overview

Morie A. Gertz is affiliated with the Mayo Clinic in the United States and has a substantial body of research primarily within the fields of medicine and biochemistry, genetics, and molecular biology. Their work spans over 744 publications in medicine and 270 in biochemistry, genetics, and molecular biology.

Their research focuses heavily on hematology, molecular biology, genetics, oncology, and nephrology, with publication counts of 261, 240, 131, 120, and 48 respectively in these subfields.

Main topics addressed in their work include:

  • Multiple Myeloma Research and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Peptidase Inhibition and Analysis
  • Parathyroid Disorders and Treatments

Some of their recent papers include:

  • Systemic Amyloidosis Recognition, Prognosis, and Therapy (2020) published in JAMA
  • Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment (2020) published in American Journal of Hematology
  • Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy (2020) published in Journal of Neurology
  • Systemic amyloidosis from A (AA) to T (ATTR): a review (2020) published in Journal of Internal Medicine
  • Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples (2020) published in Mayo Clinic Proceedings

Recurring co-authors in their publications are:

  • Shaji Kumar
  • Angela Dispenzieri
  • Prashant Kapoor
  • David Dingli
  • Taxiarchis Kourelis

Frequent publication venues where this researcher contributes include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • American Journal of Hematology
  • Blood Cancer Journal
  • Journal of Clinical Oncology

Best Publications

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

    Joan BladÉ;Diana Samson;Donna Reece;Jane Apperley

  • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand

  • Primary systemic amyloidosis : clinical and laboratory features in 474 cases

    Kyle Ra;Gertz Ma

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • POEMS syndrome: definitions and long-term outcome.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar

  • New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

    Giovanni Palladini;Angela Dispenzieri;Morie A. Gertz;Shaji Kumar

  • A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

    Robert A. Kyle;Morie A. Gertz;Philip R. Greipp;Thomas E. Witzig

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.

    RA Kyle;A Linos;CM Beard;RP Linke

  • Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

    S. Vincent Rajkumar;Suzanne Hayman;Morie A. Gertz;Angela Dispenzieri

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Amyloidosis: Pathogenesis and New Therapeutic Options

    Giampaolo Merlini;David C. Seldin;David C. Seldin;David C. Seldin;Morie A. Gertz

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
Shaji Kumar
Shaji Kumar Mayo Clinic
Francis K. Buadi
Francis K. Buadi Mayo Clinic
Robert A. Kyle
Robert A. Kyle Mayo Clinic
David Dingli
David Dingli Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
John A. Lust
John A. Lust Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in pursuing a career in healthcare but aren’t ready to commit to medical school, there are several flexible online alternatives. Nursing remains one of the most in-demand fields, and you can earn a nursing degree online from accredited institutions. These programs allow students to balance work, family, and study while gaining essential clinical skills.

Registered nurses aiming for career advancement can consider the most affordable accredited online rn to bsn programs. These bridge programs are designed for working nurses who want to deepen their expertise and leadership potential.

For experienced nurses looking to take on educator or leadership roles, a doctorate in nursing education online programs pathway enables you to influence the next generation of nurses or move into advanced research roles.

Additionally, individuals from non-nursing backgrounds can consider direct msn programs online. These accelerated options open the door to nursing careers without a prior nursing degree, offering a faster track into the health profession.

Best Scientists Citing Morie A. Gertz

Trending Scientists

Recently Published Articles